NASDAQ:IFRX - InflaRx N.V.
$50.56
 $-0.02
-0.04%
4:00PM EDT
2019-04-18
Inflarx NV, formerly Fireman BV, is a holding company for InflaRx GmbH, a Germany-based clinical-stage biopharmaceutical company. The Company's primary focus is on the development of monoclonal antibodies targeting activation products of the complement system for application in the treatment of life-threatening inflammatory diseases. Its lead product candidate, IFX-1, is an intravenously delivered first-in-class anti-C5a monoclonal antibody, undergoing Phase II clinical trial for the treatment of Hidradenitis Suppurativa (HS), a rare and chronic debilitating systemic inflammatory skin disease, and entering Phase II clinical trial for the treatment of ANCA-associated vasculitis (AAV) and other rare autoimmune diseases. The Company's product pipeline also includes IFX-2, which is in preclinical development. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  IFRX     avg for
industry  
  avg for
sector  
42 stocks weight:  23. 88   199. 07   233. 87  
42 stocks rank:  2. 72 K 1. 43 K 1. 06 K
# analyst opinions:  7. 00   14. 48   14. 09  
mean recommendation:  1. 60   2. 09   2. 01  

quick ratio:  20. 19   5. 29   1. 92  
current ratio:  20. 39   5. 64   2. 40  

target price low:  42. 10   84. 50   115. 74  
target price avg:  54. 27   110. 73   137. 39  
target price high:  67. 15   136. 41   157. 80  
1-yr high:  50. 58   114. 11   138. 85  
last close:  50. 56   87. 56   116. 78  
50-day avg:  40. 68   95. 43   123. 53  
200-day avg:  34. 18   94. 13   121. 20  
1-yr low:  23. 33   72. 67   98. 41  
volume:  224. 57 K 2. 43 M 4. 85 M
50-day avg volume:  207. 70 K 2. 72 M 4. 97 M
200-day avg volume:  82. 03 K 2. 90 M 4. 58 M

1-day return:  -0. 04 % -0. 40 % 0. 07 %
this week return:  4. 05 % -5. 72 % -4. 11 %
12-wk return:  40. 02 % 1. 78 % -0. 04 %
52-wk return:  35. 41 % 10. 81 % 14. 09 %

enterprise value (EV):  1. 22 B 51. 19 B 117. 96 B
market cap:  1. 31 B 43. 00 B 104. 52 B

shares outstanding:  25. 96 M 570. 91 M 1. 24 B
shares:  7. 78 M 571. 02 M 1. 23 B
shares short:  598. 88 K 9. 93 M 16. 79 M
shares short prior month:  443. 02 K 9. 96 M 16. 58 M
short ratio:  3. 43   5. 31   3. 30  
short % of float:  3. 38 % 5. 81 % 2. 61 %

book value:  7. 20   12. 76   26. 84  
price/book:  7. 02   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  14. 95 % --- ---
1-yr mean volatility:  0. 19 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 39   2. 39   4. 08  
forward EPS:  -3. 59   3. 97   7. 14  
P/E:  -36. 45   13. 59   22. 83  
forward P/E:  -13. 53   -20. 05   14. 49  
PE/G:  44. 69   -1. 46   1. 68  
growth:  -0. 82 % 126. 81 % 29. 29 %
earnings high:  -0. 41   1. 02   1. 63  
earnings avg:  -0. 59   0. 76   1. 51  
earnings low:  -0. 75   0. 47   1. 39  
revenue high:  80. 00 K 2. 68 B 10. 71 B
revenue avg:  20. 00 K 2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -16. 55 % -2. 80 % 5. 29 %
return on equity:  -22. 02 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  0. 89   1. 24   0. 93  
sharpe (1yr):  0. 82   0. 29   0. 60  

held % insiders:  38. 72 % 6. 38 % 3. 38 %
held % institutions:  60. 93 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : IFRX
.    + 5.724 =         5.724 :: INITIAL WEIGHT
.  + 118.768 =       124.492 :: inverse volume-to-price addition
.   + 26.675 =       151.167 :: spline projection addition
.    x 8.121 =      1227.669 :: 13 weeks' performance factor
.    x 1.381 =      1695.001 :: one-year gains+dividend factor
.    x 1.432 =      2427.283 :: industry recommendation factor
.    x 2.773 =      6730.376 :: symbol recommendation factor
.    x 0.998 =       6719.24 :: return on assets factor
.    x 0.998 =      6704.446 :: return on equity factor
.    x 3.765 =     25242.962 :: current ratio factor
.    x 1.026 =     25892.322 :: quick ratio factor
.    x 1.136 =     29425.632 :: short ratio factor
.     x 2.14 =     62964.524 :: price-to-book factor
.    x 1.459 =     91875.387 :: 5-day avg > 200-day avg
.    x 1.226 =    112624.182 :: 5-day avg > 50-day avg
.     x 1.19 =    134060.997 :: 50-day avg > 200-day avg
.    x 1.021 =    136847.322 :: P/E weight
.    x 0.387 =     52927.873 :: PE/G factor
.    x 1.583 =     83781.458 :: beta factor
.    x 0.822 =     68866.301 :: sharpe factor
.    x 0.959 =     66049.291 :: target low factor
.     x 1.09 =      72013.19 :: target mean factor
.    x 1.057 =     76138.264 :: target high factor
.    x 1.312 =     99866.631 :: industry 2-weeks return factor
.    x 0.997 =     99594.321 :: overall "drift" factor
.    x 0.851 =     84708.626 :: largest single-day jump factor
.      x 1.0 =     84694.971 :: factor hist industry gain for week 15
.   cubeRoot =        43.916 :: reduced to standardize
.   - 20.036 =        23.879 :: add/subtract for performance
.                     23.879 :: FINAL WEIGHT for NASDAQ:IFRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org